# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Psychedelics-focused mental health care company Numinus Wellness Inc. (TSXV: NUMI) (OTCQX: NUMIF) announced its fiscal fourth q...
The Week In Psychedelics British Prime Minister Boris Johnson To Consider Psilocybin Legalization
The Week In Psychedelics Seattle Decriminalizes Psychedelics Along With California City
The Week In Psychedelics:
Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mesc...
Psychedelics ETFs Are Gaining Traction Defiance ETFs launched the “Next Gen Altered Experience ETF,” the first U.S.-listed ETF...
PharmaDrug Inc. (CSE: BUZZ) (Pink: LMLLF) announced an FDA-granted Orphan Drug Designation to its wholly owned subsidiary Sairi...
Numinus Wellness (Pink: LKYSF) (TSXV: NUMI) announced the launch of a new clinical trial that will add information to an indust...
Cannabis Countdown: Top 10 Marijuana and Psychedelic Stock News Stories of the Week